Company Overview and News

Queensland man fined $10,000 for killing massive crocodile

Luke Stephen Orchard pleaded guilty in Rockhampton Magistrates Court on Friday to unlawfully taking a class three protected animal.
Upvote Downvote

Accused croc killer deserves award: Katter

Federal MP Bob Katter believes the man accused of shooting dead a 5.2 metre saltwater crocodile should receive a "humanity award" instead of being prosecuted.
Upvote Downvote

Man charged over death of giant Queensland croc

Three months after the carcass of a 5.2-metre crocodile was found near Rockhampton, police have charged a man over the killing of the reptile.
Upvote Downvote

Croc giant's killer still at large, $5000 bounty unclaimed

The Rockhampton crocodile murderer is still at large two months after the victim's 5.2-metre body was discovered.
Upvote Downvote

$5000 bounty on croc killer after giant 5.2-metre reptile shot in central Qld

A massive 5.2-metre saltwater crocodile has been found shot dead in central Queensland, which locals describe as the largest-ever carcass pulled from the river in the area.
Upvote Downvote

Giant 5.2-metre croc shot dead in central Queensland

The reptile was found in the Fitzroy River at Rockhampton on Thursday with the bullet still in its head.
Upvote Downvote

Convicted murderer seeks parole amid claims of innocence

A convicted murderer and rapist who maintains his innocence after more than a quarter of a century behind bars has been given another chance to argue his way out of a Queensland prison.
Upvote Downvote

Butcher had one-hour window to kill friend: court

An experienced halal butcher charged with murder had a one-hour window in which to decapitate his friend and dispose of his body, a court has heard.
Upvote Downvote

Amazing photos highlight dangerous life of Kimberley sawfish

An astonishing photograph has provided an arresting illustration to new Murdoch University research on the dangerous life of the critically endangered sawfish of the state's Kimberley region. 
Upvote Downvote

Rockhampton flood recedes, roads reopen, rubbish trucks at the ready

Rockhampton is keeping up its clean-up effort after floodwaters swamped the central Queensland city last week.
Upvote Downvote

Cyclone Debbie response to be reviewed as Rockhampton residents start clean-up

A major review has been ordered into how Queensland emergency services responded to Tropical Cyclone Debbie, as Rockhampton started to clean-up on Sunday.
Upvote Downvote

Treading water, she was ready to say goodbye but her horse had one kick left

Danina Ward had been treading water for more than half an hour desperately trying to keep her horse's head above the surface when her partner turned to her and told her it was OK to say goodbye to the thoroughbred.
Upvote Downvote

Premier commits to permanent Rockhampton levees as floodwaters slowly recede

The Premier has committed to funding permanent flood levees in Rockhampton and threw down the challenge to the federal government to follow suit on Friday.
Upvote Downvote

Fake cancer sufferer Belle Gibson ordered to pay $30,000 in court costs

Disgraced health personality Belle Gibson has to pay $30,000 towards the legal costs of Consumer Affairs Victoria and has been banned from making deceptive claims about her health in connection with wellbeing advice.
Upvote Downvote

SES receives no emergency calls as Fitzroy River peaks

Rockhampton residents, who knew about the flooding event last week, were prepared as the slow-moving flood moved across the city and affected hundreds of homes.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...